Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

To do no harm — and the most good — with AI in health care

Drawing from real-life scenarios and insights shared at the RAISE (Responsible AI for Social and Ethical Healthcare) conference, we highlight the critical need for AI in health care (AIH) to primarily benefit patients and address current shortcomings in health care systems such as medical errors and access disparities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Acknowledgements

The RAISE symposium was supported by grants from the Harvard Medical School Center for Bioethics, the Harvard Medical School Office of the Dean, the Gordon and Betty Moore Foundation, The Health Foundation, Microsoft Corporation, and Apple.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Isaac S. Kohane.

Ethics declarations

Competing interests

The authors declare the following competing interests: L.A. reports a senior advisor contractor role with the National Academy of Medicine; consulting fees from the National Hospice & Palliative Care Organization, X4 Health, David Nagel, MD and Nagel Pain Community; speakers’ fee from Gotham Artists, Executive Speakers Bureau, St. Luke’s Health System and Salem Health; corporate board member or advisor or stock options at T2 Biosystems and TMA Precision Health. D.B. reports grants from the Commonwealth Fund; advisory role at Aledade, Carol Emmott Foundation, New England Journal of Medicine, New England Journal of Medicine AI and Josiah Macy Foundation; stock options at Aledade, Nova Cor and Xhale. A.J.B. reports grants from the National Institutes of Health, Merck, Genentech, Peraton, Priscilla Chan and Mark Zuckerberg and Bakar Family Foundation; royalties, licenses or consulting fees from NuMedii, Personalis, Progeny, Samsung, Gerson Lehman Group, Dartmouth, Gladstone Institute, Boston Children’s Hospital and Mango Tree Corporation; honoraria or speakers or expert testimony fees from Boston Children’s Hospital, Johns Hopkins University, Endocrine Society, Alliance for Academic Internal Medicine, Roche, Children’s Hospital of Philadelphia, University of Pittsburgh Medical Center, Cleveland Clinic, University of Utah, Society of Toxicology, Mayo Clinic, Pfizer, Cerner, Johnson and Johnson and The Transplantation Society; Foresight; patents issued or pending with Personalis, NuMedii, Carmenta, Progenity, Stanford, University of California, San Francisco; participation on a Data Safety Monitoring Board or Advisory Board at Washington University in Saint Louis, Regenstreif Institute. Geisinger and University of Michigan; Stock or stock options with Sophia Genetics, Allbirds, Coursera, Digital Ocean, Rivian, Invitae, Editas Medicine, Pacific Biosciences, Snowflake, Meta, Alphabet, 10x Genomics, Snap, Regeneron, Doximity, Netflix, Illumina, Royalty Pharma, Starbucks, Sutro Biopharma, Pfizer, Biontech, Advanced Micro Devices, Amazon, Microsoft, Moderna, Tesla, Apple, Personalis and Lilly. D. deB. reports speaker honorarium to IHI Leadership Summit. J. Drazen reports unpaid role as Member of the Board of Trustees of Nantucket Cottage Hospital. B.J.E. reports grants from National Institutes of Health Common Fund’s Bridge2AI Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI. NIH OT2OD0327 (9/1/2022-8/31/2026); speakers honoraria from American College of Legal Medicine, University of Minnesota, Columbia University School of Medicine; minor holdings of Amazon stock and Pfizer stock. S.M.H. reports support from Harvard Medical School and stock or stock options from PathAI, Inc. P.L. reports employment and stock options with Microsoft Corporation. G.S. reports support from Duke University and Apple; grants from the Simons Foundation, National Science Foundation and Office of Naval Research; stock or stock options with Apple. E.V. reports grants from the Swiss National Science Foundation and Botnar Foundation; consulting fees or other honoraria from Johns Hopkins University- consultant for Bioethics Academy and Roche diagnostics; participation on a Data Safety Monitoring Board or Advisory Board for Meck: Digital Ethics Advisory Panel and IQVIA: Ethics Advisory Panel; role as co-chair for WHO expert group on ethics and governance of AI in Health. M.C. reports a leadership or advisory role with Coalition for Health AI. C.H. reports grants or contracts with Novo Nordisk; participation on a Data Safety Monitoring Board or Advisory Board at Novo Nordisk Foundation, UK Biobank and MRC Advisory Board; leadership or advisory role at CRUK Data Science Advisory Board. A.K.M is a paid deputy editor at NEJM AI, a publication of the Massachusetts Medical Society. I.S.K is Editor-in-Chief at NEJM AI, a publication of the Massachusetts Medical Society; he reports honoraria for lectures or other educational activities at the University of Massachusetts (Amherst), Morehouse, Simons Foundation, Cincinnati Children’s Hospital and University of Pennsylvania; board membership with Canary Medical, Pulse Data and Inovalon. Authors may have received financial support from their institutions or the NEJM AI/MMS to attend the RAISE in person. C.B.G., P.F.B. J. Dixon, G.S.O., R.R., N.B., J.B.P. R.S. and H.S. report no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goldberg, C.B., Adams, L., Blumenthal, D. et al. To do no harm — and the most good — with AI in health care. Nat Med 30, 623–627 (2024). https://doi.org/10.1038/s41591-024-02853-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02853-7

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing